|
|
| Iran Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| For BMI' s Q309 Iran Pharmaceutical and Healthcare Report, we expect a 9.0% compound annual growth
rate (CAGR) for the total pharmaceutical market, meaning an increase in total value from US$2.27bn in
2008 to US$3.50bn by 2013. We believe the main drive ... |
| Israel Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| In BMIfs updated Business Environment Rankings (BER) for Q309, Israel continued slipping down the
table, now ranking seventh out of the 17 Middle East and African (MEA) markets surveyed. While the
country scores strongly across the country structure an ... |
| Jordan Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| BMI has revised its extended forecast for Jordan' s pharmaceutical and healthcare market for our Q309
report. We expect the total drug market to grow from US$370mn in 2008 to US$519mn by 2013,
representing a compound annual growth rate (CAGR) of 7.01%. ... |
| Kenya Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| BMI calculates Kenya' s pharmaceutical expenditure to have been KES15.85bn (US$229mn) in 2008. By
2013, we expect the total amount spent on prescription and over-the-counter (OTC) medicines to have
reached a value of KES29.89bn (US$395mn) equating to a ... |
| Kuwait Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| Kuwaitfs pharmaceutical market is small in regional terms. Combined sales of over-the-counter (OTC)
and prescription drugs reached a total of US$377mn in 2008, and we expect this to reach US$462mn by
2013 ? representing a compound annual growth rate (C ... |
| Latvia Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| BMI calculates the Latvian pharmaceutical market to have been worth LVL256mn (US$512mn) in 2008,
and by 2013, drug expenditure is expected to reach a value of LVL352mn. In US dollar terms, however,
as a result of the weakening lat, drug market spending ... |
| Lebanon Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| Lebanon remains a strong pharmaceutical market in the Middle East and Africa (MEA) region. In BMIfs
updated Business Environment Ratings for Q309, Lebanon holds a respectable 13th position. The
countryfs pharmaceutical market was worth US$500mn in 200 ... |
| Levodopa (CAS 59-92-7) Market Report 2009 |
|
| Table of Contents Published: 2009/06 Published by: Merchant Research & Consulting LTD. |
| The study 'Levodopa (CAS 59-92-7) Market Report 2009' presents an overview of the Praduct market globally and regionally by contemplating and analyzing its parameters. ... |
| Liver Disease Treatments: The Global Market |
|
| Table of Contents Published: 2009/06 Published by: BCC Research |
| BCC' s goal in conducting this study is to provide an overview of the current and potential aspects of the global market for liver diseases treatments. The report determines the market size and market leaders, provides a market overview, and examines fact ... |
| Mega-Mergers: Executing Change in the Pharma Industry |
|
| Table of Contents Published: 2009/06 Published by: Decision Resources, Inc. |
| If consolidation is so advantageous for boosting a pharma company to a new level of productivity, why has Pfizer engaged in not just one but three mega-mergers in the past ten years: $92.3 billion for Warner-Lambert in 2000, $60 billion for Pharmacia in 2 ... |
| Merck KGaA: Pipeline, Products, Performance, Potential |
|
| Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence |
| Merck' s pharmaceutical operations are divided into the Merck Serono business and Consumer Health Care. For the former, research and marketing efforts are centred on two key therapeutic areas, namely Oncology and Neurology. ... |
| New Strategies in Academic-Industry Collaborations |
|
| Table of Contents Published: 2009/06 Published by: Decision Resources, Inc. |
| Major pharmaceutical companies are showing increased interest in directly sponsoring academic research to access innovation and fill dwindling pipelines. Recent agreements involve higher levels of collaboration and funding, are broader in scope, and focus ... |
| Nigeria Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| In BMI' s Q309 update of the Pharmaceutical Business Environment Rankings for the Middle East and
Africa (MEA) region, Nigeria is once again ranked second-last out of the 17 key regional markets, above
only Zimbabwe. Globally, Nigeria is also ranked sec ... |
| Nrt Smoking Cessation Aids in Argentina |
|
| Table of Contents Published: 2009/06 Published by: Euromonitor International |
| Euromonitor International' s NRT Smoking Cessation Aids in Argentina report offers a comprehensive guide to the size and shape of the market at a national level. ... |
| Nrt Smoking Cessation Aids in Norway |
|
| Table of Contents Published: 2009/06 Published by: Euromonitor International |
| Euromonitor International' s NRT Smoking Cessation Aids in Norway report offers a comprehensive guide to the size and shape of the market at a national level. ... |
| NRT Smoking Cessation Aids in Ukraine |
|
| Table of Contents Published: 2009/06 Published by: Euromonitor International |
| Euromonitor International' s NRT Smoking Cessation Aids in Ukraine report offers a comprehensive guide to the size and shape of the market at a national level. ... |
| Oncology Partnering Agreements in Pharma, Biotech and Diagnostics |
|
| Table of Contents Published: 2009/06 Published by: CurrentPartnering, a division of Wildwood Ventures Limited |
| The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the worlds leading biopharma companies.
The report provide ... |
| OTC Healthcare - Cameroon |
|
| Table of Contents Published: 2009/06 Published by: Euromonitor International |
| Euromonitor International' s OTC Healthcare Products in Cameroon report offers a comprehensive guide to the size and shape of the market at a national level. ... |
| OTC Healthcare - Iran |
|
| Table of Contents Published: 2009/06 Published by: Euromonitor International |
| Euromonitor International' s OTC Healthcare Products in Iran report offers a comprehensive guide to the size and shape of the market at a national level. ... |
| OTC Healthcare in Argentina |
|
| Table of Contents Published: 2009/06 Published by: Euromonitor International |
| The Argentine market for OTC healthcare products saw growth during 2008, due to higher advertising expenditure aiming to make consumers aware of the benefits of products such as Elea' s Mox 12 Hs naproxen, or Boehringer' s Buscapina Fem IBS treatment. ... |
| OTC Healthcare in Norway |
|
| Table of Contents Published: 2009/06 Published by: Euromonitor International |
| Brand dynamics are of increasing importance, as OTC healthcare products are more widely distributed through mass retail outlets due to the recent liberalisation of distribution laws. ... |
| OTC Healthcare in Ukraine |
|
| Table of Contents Published: 2009/06 Published by: Euromonitor International |
| By the end of the review period, Ukrainian consumers continued to buy more OTC medicines due to growing levels of self-medication. ... |
| Pakistan Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| Pakistan' s pharmaceutical expenditure was valued at PKR127bn (US$2bn) in 2008. Between 2009 and
2013, BMI forecasts that the market should grow at a nominal CAGR of 12.7% in local currency to reach
PKR230bn (US$3bn) in 2013, with population growth bein ... |
| Pharmaceutical and healthcare market in Poland 2009 |
|
| Table of Contents Published: 2009/06 Published by: PMR |
| The latest report from PMR - Pharmaceutical and Healthcare Market in Poland 2009 - provides information on the size of the pharmaceutical market in Poland in 2002-2008 and market size projections for 2009-2011. The main forecasts estimate the size of the ... |
| Pharmaceutical Pricing and Reimbursement in China |
|
| Table of Contents Published: 2009/06 Published by: Decision Resources, Inc. |
| With a growth rate of more than 20% per year, the Chinese pharmaceutical market is set to become the third largest in the world in 2011. A radical healthcare reform package recently unveiled by the government will more than double public healthcare expend ... |
| Pharmacogenomics for Clinical Use and in Drug Development |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat specific segments of the popul ... |
| Pharmacogenomics: Delivering on the Promise |
|
| Table of Contents Published: 2009/06 Published by: Insight Pharma Reports |
| Pharmacogenomics (PGx) is often considered the great new wave in medicine, promising better, safer, and more affordable healthcare. Yet its adoption and widespread use in the clinic is up against some tremendous challenges. ... |
| Philippines Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| The Philippines remains ranked as the 11th most attractive pharmaceutical market among 15 major
countries in the Asia Pacific region, according to BMIfs Business Environment Rankings for Q309.
Nevertheless, BMI expects the country to improve this posit ... |
| Roche: Pipeline, Products, Performance, Potential |
|
| Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence |
| Roche achieved strong sales results in 2007, coupled with a significant improvement in operating profitability, however, this performance could not be replicated as the company felt the effects of the global economic crisis, as well as a significant downt ... |
| Singapore Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| In BMIfs Business Environment Rankings (BER) matrix for Q309, Singapore slipped from fourth to
sixth position out of the 15 key countries in the Asia Pacific region, in line with worsening economic
conditions and their impact on the pharmaceutical mark ... |
| Slovakia Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| Following an update to our macroeconomic variables as a result of both the eurozone accession and
global economic downturn, BMI now expects Slovakiafs pharmaceutical expenditure to grow to
EUR2.06bn (US$2.62bn) by 2013. While this is below our previous ... |
| Slovenia Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| In BMI's Business Environment Ranking table adjusted for Q309, Slovenia continued to improve its
position in the Central and Eastern European (CEE) matrix and ranks 9th, up from 11th and 12th in the
previous two quarters respectively. ... |
| Thailand Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| In BMIfs Pharmaceutical Environment Ranking table for Q309, Thailand remains placed 10th, out of the
15 key markets surveyed in the Asia Pacific region. Thailandfs growing and ageing population and the
expansion of universal healthcare coverage repres ... |
| The Pharmaceutical Market: Argentina |
|
| Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence |
| Espicom' s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of ... |
| The Pharmaceutical Market: Australia |
|
| Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence |
| Espicom' s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of ... |
|
|
Top
View Cart
